Font Size: A A A

CELL Series: Finding the Eligible Patient for Lung Cancer Screening

Jan
27
CELL Series: Finding the Eligible Patient for Lung Cancer Screening
-
Zoom

 

Lung cancer screening with annual low-dose CT can save lives by detecting lung cancer at an earlier, more treatable stage. Yet many eligible individuals remain unscreened, often because smoking history is not consistently assessed or because eligibility conversations are challenging to incorporate into routine care. At the same time, patients and providers frequently ask why environmental risk factors such as secondhand smoke exposure, radon exposure and occupational exposures are not included in current screening eligibility criteria.

This webinar will review the current evidence-based eligibility recommendations for lung cancer screening, explain how the criteria were developed and discuss why certain environmental and occupational risk factors, while important contributors to lung cancer risk, are not currently used to determine screening eligibility. Participants will explore practical strategies for systematically identifying eligible patients through standardized tobacco use assessment, accurate pack-year documentation and electronic health record workflows. The session also will introduce principles of non-stigmatizing, patient-centered communication that encourage productive conversations about lung cancer risk and screening while reducing shame and blame associated with tobacco use.

Register here

Our featured speaker:

Jamie Studts, PhD
Professor, Division of Medical Oncology, Department of Medicine, Program Co-Leader, Cancer Prevention and Control
University of Colorado School of Medicine

Dr. Jamie L. Studts is a Professor of Medical Oncology at the University of Colorado School of Medicine and Scientific Director of Behavioral Oncology. Dr. Studts also serves as the Co-Leader for the Cancer Prevention and Control program and Co-Director of the Population Health Shared Resource at the University of Colorado Cancer Center. Dr. Studts is a licensed clinical health psychologist, and his interests address behavioral aspects of tobacco-related malignancies. His research develops and tests interventions to promote informed/shared decision making and behavior change among patients and clinicians regarding prevention, screening, and survivorship of lung and head/neck cancer. Dr. Studts is the Principal Investigator of the Kentucky LEADS Collaborative, and he previously served on the Institute of Medicine National Cancer Policy Forum addressing Implementation of Lung Cancer Screening. In 2019 he received the Centerstone Healthcare Advocacy award in recognition of his efforts to reduce the burden of lung cancer in Kentucky.